Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK. (Q39535341)

12 September 2017

title

Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK. (English)

1 reference

12 September 2017

main subject

hepatocellular carcinoma

1 reference

Yang Gao

1

1 reference

12 September 2017

Hua-Xing Li

2

1 reference

12 September 2017

Li-Tao Xu

3

1 reference

12 September 2017

Peng Wang

4

1 reference

12 September 2017

Li-Yan Xu

5

1 reference

12 September 2017

Lorenzo Cohen

6

1 reference

12 September 2017

Pei-Ying Yang

7

1 reference

12 September 2017

Ke Gu

8

1 reference

12 September 2017

Zhi-Qiang Meng

9

1 reference

12 September 2017

publication date

27 May 2011

1 reference

Molecular Biology Reports

12 September 2017

published in

1 reference

12 September 2017

volume

39

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

1683-1689

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-011-0908-x

12 September 2017

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a pha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Drug combination studies and their synergy quantification using the Chou-Talalay method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Calreticulin expression levels and endoplasmic reticulum during late oogenesis and early embryogenesis of Rhodnius prolixus Stahl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Molecular mechanisms of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

AKT and oxidative stress team up to kill cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0908-X

Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells

21 January 2018

1 reference

12 December 2020

[Schedule-dependent effects of sorafenib in combination with paclitaxel on human hepatocellular carcinoma cell line BEL-7402]

1 reference

12 December 2020

Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro

1 reference

12 December 2020

Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies

1 reference

12 December 2020

Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells.

1 reference

12 December 2020

Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells

1 reference

12 December 2020

Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells

1 reference

12 December 2020

10.1007/S11033-011-0908-X

Identifiers

DOI

1 reference

12 September 2017

1 reference